Neuberg Diagnostics expands its Presence in India with inauguration of a new lab in Telangana

New Delhi, July 13, 2021: India’s fourth largest pathology player, Neuberg Diagnostics Private Limited inaugurated a new state of the art pathology lab in Khammam, Telangana. The commencement of operations of the new lab in Khammam, Telangana is another step of Neuberg Diagnostics’ towards expanding its domestic and international presence. Last year, it had entered eastern and northern states by setting up greenfield labs and is expecting to be a significant player in those markets in this financial year. It had also set up a CLIA approved molecular and genomic lab in the USA, in FY 22 with COVID testing facilities.

The new lab was inaugurated by SH. Puvvada Ajay Kumar, Minister of Transport, Telangana Government and SH. Nama Nageshwar Rao, local MP, TRS Party, SH. Errabelli Dayakar Rao, Minister of panchayat Raj & Rural Development, Telangana.

The group had closed FY 21 with a gross revenue of INR 800 crore. As a part of the expansion plan in FY22, Neuberg will be launching 30 new labs and more than 500 collection centres in domestic and international markets. It will also be putting up technology incubation centers in USA and Europe to access the latest technologies and make developing countries ready for precision diagnostics in the evolving personalized medicine arena.

Mr. A Ganesan, Group Vice Chairman, Neuberg Diagnostics said*, “Apart from inorganic growth, we are also setting up greenfield labs and mobile COVID testing units in order to increase the reach of quality testing in small towns in India. In terms of international expansion, we are looking to expand rapidly in the USA and also planning to open diagnostics facilities in East Africa and in West Asia, We will be commissioning a new state of art testing facility in Dubai which will act as a hub in West Asia . We are also planning to have our presence in Sri Lanka, Nepal, Bangladesh, and Germany during this Financial year”

Speaking on the development, *MS. Aishwarya Vasudevan, Group Chief Operating Officer, Neuberg Diagnostics Private Limited, said*, “The 2nd wave of covid had a major impact on the Indian healthcare ecosystem. There is a demand for superior healthcare services, right from diagnosis to treatment, in Tier II & III cities…our efforts are directed towards filling this gap. This new lab at Khammam is an important milestone in Neuberg’s vision to helm the battle against disease by making available most advanced diagnostics tests within the reach of the common man across the globe, with a relentless focus on quality, cutting-edge technology and uncompromising ethics.”

Currently, Neuberg Diagnostics has 109 labs in India and 15 labs overseas (USA, South Africa, and Dubai). With 14 approved labs for Covid testing in India, the group has the capacity to process more than 65000 tests per day. Additionally, the group is also doing COVID tests from 3 of its labs in South Africa and 1 in the USA.

Corporate Comm India (CCI Newswire)